213 related articles for article (PubMed ID: 27074628)
1. Antiproliferative activity of bicyclic benzimidazole nucleosides: synthesis, DNA-binding and cell cycle analysis.
Sontakke VA; Lawande PP; Kate AN; Khan A; Joshi R; Kumbhar AA; Shinde VS
Org Biomol Chem; 2016 Apr; 14(17):4136-45. PubMed ID: 27074628
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of benzimidazole nucleosides and their anticancer activity.
Shinde VS; Lawande PP; Sontakke VA; Khan A
Carbohydr Res; 2020 Dec; 498():108178. PubMed ID: 33045644
[TBL] [Abstract][Full Text] [Related]
3. Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.
Cindrić M; Jambon S; Harej A; Depauw S; David-Cordonnier MH; Kraljević Pavelić S; Karminski-Zamola G; Hranjec M
Eur J Med Chem; 2017 Aug; 136():468-479. PubMed ID: 28525845
[TBL] [Abstract][Full Text] [Related]
4. Reprofiling of full-length phosphonated carbocyclic 2'-oxa-3'-aza-nucleosides toward antiproliferative agents: Synthesis, antiproliferative activity, and molecular docking study.
Bkhaitan MM; Mirza AZ; Abdalla AN; Shamshad H; Ul-Haq Z; Alarjah M; Piperno A
Chem Biol Drug Des; 2017 Nov; 90(5):679-689. PubMed ID: 28371417
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues.
Huang LH; Xu HD; Yang ZY; Zheng YF; Liu HM
Steroids; 2014 Apr; 82():1-6. PubMed ID: 24378780
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles.
Hranjec M; Starčević K; Pavelić SK; Lučin P; Pavelić K; Karminski Zamola G
Eur J Med Chem; 2011 Jun; 46(6):2274-9. PubMed ID: 21439689
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of new β-carboline-bisindole compounds as DNA binding, photocleavage agents and topoisomerase I inhibitors.
Kovvuri J; Nagaraju B; Nayak VL; Akunuri R; Rao MPN; Ajitha A; Nagesh N; Kamal A
Eur J Med Chem; 2018 Jan; 143():1563-1577. PubMed ID: 29129513
[TBL] [Abstract][Full Text] [Related]
8. Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors.
Galal SA; Khairat SHM; Ali HI; Shouman SA; Attia YM; Ali MM; Mahmoud AE; Abdel-Halim AH; Fyiad AA; Tabll A; El-Shenawy R; El Abd YS; Ramdan R; El Diwani HI
Eur J Med Chem; 2018 Jan; 144():859-873. PubMed ID: 29316526
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors.
Akhtar MJ; Khan AA; Ali Z; Dewangan RP; Rafi M; Hassan MQ; Akhtar MS; Siddiqui AA; Partap S; Pasha S; Yar MS
Bioorg Chem; 2018 Aug; 78():158-169. PubMed ID: 29571113
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, DNA binding ability and anticancer activity of 2-heteroaryl substituted benzimidazoles linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates.
Kamal A; Pogula PK; Khan MN; Seshadri BN; Sreekanth K
Med Chem; 2013 Aug; 9(5):651-9. PubMed ID: 23301523
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a 3'-C-ethynyl-β-d-ribofuranose purine nucleoside library: Discovery of C7-deazapurine analogs as potent antiproliferative nucleosides.
Hulpia F; Noppen S; Schols D; Andrei G; Snoeck R; Liekens S; Vervaeke P; Van Calenbergh S
Eur J Med Chem; 2018 Sep; 157():248-267. PubMed ID: 30098481
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Anticancer Properties of Novel Truncated Carbocyclic Nucleoside Analogues.
Sivakrishna B; Islam S; Panda A; Saranya M; Santra MK; Pal S
Anticancer Agents Med Chem; 2018; 18(10):1425-1431. PubMed ID: 29577866
[TBL] [Abstract][Full Text] [Related]
14. Microwave-assisted synthesis of sec/tert-butyl 2-arylbenzimidazoles and their unexpected antiproliferative activity towards ER negative breast cancer cells.
Abdul Rahim AS; Salhimi SM; Arumugam N; Pin LC; Yee NS; Muttiah NN; Keat WB; Abd Hamid S; Osman H; Mat Ib
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1255-60. PubMed ID: 23061895
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid-DACH conjugate: comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies.
Arjmand F; Yousuf I; Hadda Tb; Toupet L
Eur J Med Chem; 2014 Jun; 81():76-88. PubMed ID: 24826817
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents.
Abdelgawad MA; Bakr RB; Omar HA
Bioorg Chem; 2017 Oct; 74():82-90. PubMed ID: 28772160
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of diastereoisomerically pure N,O-nucleosides.
Bortolini O; De Nino A; Eliseo T; Gavioli R; Maiuolo L; Russo B; Sforza F
Bioorg Med Chem; 2010 Oct; 18(19):6970-6. PubMed ID: 20813537
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of substituted phenanthrene-9-benzimidazole conjugates: Cytotoxicity evaluation and apoptosis inducing studies.
Kumar NP; Sharma P; Kumari SS; Brahma U; Nekkanti S; Shankaraiah N; Kamal A
Eur J Med Chem; 2017 Nov; 140():128-140. PubMed ID: 28923381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
